Related Experiment Video
Updated: Jul 23, 2026
10:03
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Acute Meningitis
1Department of Neurology, Klinikum Grosshadern, Ludwig-Maximilians-University of Munich, Marchioninistr. 15, D-81377 Munich, Germany.
Current Infectious Disease Reports
|November 30, 2000
Summary
Bacterial meningitis treatment is challenged by antibiotic resistance. Targeting reactive oxygen species (ROS) and poly(ADP-ribose) polymerase (PARP) may limit brain damage and improve outcomes.
Area of Science:
- Neuroscience
- Infectious Diseases
- Pharmacology
Background:
- Bacterial meningitis incidence is declining due to vaccines, but antibiotic-resistant strains are increasing.
- Pathophysiology involves inflammatory mediators, reactive oxygen species (ROS), reactive nitrogen species, and matrix metalloproteinases.
- ROS and peroxynitrite contribute to brain damage via lipid peroxidation and DNA damage, activating poly(ADP-ribose) polymerase (PARP).
Purpose of the Study:
- To explore novel therapeutic strategies for bacterial meningitis.
- To investigate the role of ROS, peroxynitrite, lipid peroxidation, and PARP activation in meningitis-associated brain injury.
- To identify agents that can limit brain damage and improve patient outcomes.
Main Methods:
- Review of animal studies on bacterial meningitis pathophysiology.
- Analysis of inflammatory mediators, ROS, reactive nitrogen species, and their cytotoxic effects.
- Examination of the role of lipid peroxidation and PARP activation in brain injury.
Main Results:
- Reactive oxygen species (ROS) and peroxynitrite induce lipid peroxidation and DNA single-strand breakage.
- DNA damage activates poly(ADP-ribose) polymerase (PARP).
- Lipid peroxidation and PARP activation are implicated in meningitis-associated intracranial complications and brain injury.
Conclusions:
- Agents targeting ROS and peroxynitrite production may offer novel therapeutic strategies.
- Interfering with lipid peroxidation and PARP activation could limit meningitis-associated brain damage.
- Novel therapeutic approaches targeting these pathways may improve outcomes for bacterial meningitis.
Related Concept Videos
01:24Bacterial Meningitis
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:26Brain Abscess l: Introduction
A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...